Baseline Characteristics of Treatment and Control Groups
| Treatment Group (n = 55) | Control Group (n = 54) | P | |
|---|---|---|---|
| Age (years) | 60.5 ± 10.7 | 59.9 ± 9.2 | .73 |
| Race | .55 | ||
| White | 76 (42) | 76 (41) | |
| Black | 16 (9) | 13 (7) | |
| Latino | 2 (1) | 5 (3) | |
| Asian | 5 (3) | 5 (3) | |
| Sex | .46 | ||
| Male | 58 (32) | 59 (32) | |
| Female | 42 (23) | 41 (22) | |
| Body mass index (kg/m2) | 31.9 ± 6.4 | 32.9 ± 6.4 | .38 |
| Patients using insulin | 38 (21) | 33 (18) | .46 |
| Cinnamon intake | .32 | ||
| High | 5 (3) | 2 (1) | |
| Normal | 95 (52) | 98 (53) | |
| Baseline hemoglobin A1c (%) | 8.47 ± 1.8 | 8.28 ± 1.3 | .54 |
| Diabetes medications, baseline (n) | 1.76 ± 0.9 | 1.91 ± 0.9 | .39 |
| Diabetes medications, final (n) | 1.74 ± 0.9 | 2.02 ± 0.9 | .12 |
| Diabetes medication dosage adjustments per patient (n) | 0.3 ± 0.2 | 0.3 ± 0.2 | 1.0 |
| Patients with new diabetes medications added during the study period (n) | 4 | 5 | |
| Patients who had diabetes medications stopped during the study period (n) | 4 | 4 | |
| >75% compliant with taking cinnamon | — | 91 (42) |
Values are shown as mean ± SD or % (n), unless otherwise indicated.